Dissecting immunosuppression in brain tumor tissue
Description of the granted funding
Immunotherapy is associated with efficient and long-lasting treatment responses in several cancers, but only a subpopulation of patients respond to current approaches. Partly because of this, it is important to further stratify the patients based on their predicted immune response. In the project, we will categorize patients based on the type of immunosuppression in tumor microenvironment and investigate which regulators drive tumor-induced immunosuppression in brain tumors. Computing, analysis of large-scale measurement data, wet-lab experimentation, and patient-derived brain tumor material will be used. The obtained results aim to clarify which treatment options could work the best for each patient. The project can also lead to the identification of novel treatment targets for personalized immunotherapy.
Show moreStarting year
2020
End year
2022
Granted funding
Role in consortium of the Academy of Finland
Leader
Other information
Funding decision number
333545
Fields of science
Biomedicine
Research fields
Biolääketieteet
Themes
Nuori tutkijasukupolvi 2019
Identified topics
cancer